BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 32035658)

  • 1. Pathological and therapeutic implications of eosinophil-derived semaphorin 4D in eosinophilic chronic rhinosinusitis.
    Tsuda T; Nishide M; Maeda Y; Hayama Y; Koyama S; Nojima S; Takamatsu H; Okuzaki D; Morita T; Nakatani T; Kato Y; Nakanishi Y; Futami Y; Suga Y; Naito Y; Konaka H; Satoh S; Naito M; Izumi M; Obata S; Nakatani A; Shikina T; Takeda K; Hayama M; Inohara H; Kumanogoh A
    J Allergy Clin Immunol; 2020 Mar; 145(3):843-854.e4. PubMed ID: 32035658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased CD69 expression on activated eosinophils in eosinophilic chronic rhinosinusitis correlates with clinical findings.
    Yun Y; Kanda A; Kobayashi Y; Van Bui D; Suzuki K; Sawada S; Baba K; Yagi M; Asako M; Okazaki H; Ikeda H; Kawamura S; Nakamura A; Dombrowicz D; Tomoda K; Iwai H
    Allergol Int; 2020 Apr; 69(2):232-238. PubMed ID: 31928947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. γδT cells contribute to type 2 inflammatory profiles in eosinophilic chronic rhinosinusitis with nasal polyps.
    Li X; Wang Z; Chang L; Chen X; Yang L; Lai X; Li S; Huang J; Huang Z; Wu X; Bellanti JA; Zheng SG; Zhang G
    Clin Sci (Lond); 2019 Nov; 133(22):2301-2315. PubMed ID: 31722010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lower Airway Inflammation in Eosinophilic Chronic Rhinosinusitis as Determined by Exhaled Nitric Oxide.
    Kambara R; Minami T; Akazawa H; Tsuji F; Sasaki T; Inohara H; Horii A
    Int Arch Allergy Immunol; 2017; 173(4):225-232. PubMed ID: 28848094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Eosinophil-derived neurotoxin enhances airway remodeling in eosinophilic chronic rhinosinusitis and correlates with disease severity.
    Tsuda T; Maeda Y; Nishide M; Koyama S; Hayama Y; Nojima S; Takamatsu H; Okuzaki D; Kinehara Y; Kato Y; Nakatani T; Obata S; Akazawa H; Shikina T; Takeda K; Hayama M; Inohara H; Kumanogoh A
    Int Immunol; 2019 Feb; 31(1):33-40. PubMed ID: 30239772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced Interferon-β Response Contributes to Eosinophilic Chronic Rhinosinusitis.
    Jang YJ; Lim JY; Kim S; Lee Y; Kweon MN; Kim JH
    Front Immunol; 2018; 9():2330. PubMed ID: 30455684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased exhaled nitric oxide and its oxidation metabolism in eosinophilic chronic rhinosinusitis.
    Takeno S; Taruya T; Ueda T; Noda N; Hirakawa K
    Auris Nasus Larynx; 2013 Oct; 40(5):458-64. PubMed ID: 23489830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced nasal nitric oxide levels in patients with eosinophilic chronic rhinosinusitis.
    Yoshida K; Takabayashi T; Imoto Y; Sakashita M; Narita N; Fujieda S
    Allergol Int; 2019 Apr; 68(2):225-232. PubMed ID: 30348485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Group 2 innate lymphoid cells are increased in nasal polyps in patients with eosinophilic chronic rhinosinusitis.
    Tojima I; Kouzaki H; Shimizu S; Ogawa T; Arikata M; Kita H; Shimizu T
    Clin Immunol; 2016 Sep; 170():1-8. PubMed ID: 27422491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Which are the best murine models to study Eosinophilic Chronic Rhinosinusitis? A contemporary review.
    Leite-Santos F; Tamashiro E; de Andrade Batista Murashima A; Anselmo-Lima WT; Valera FCP
    Braz J Otorhinolaryngol; 2023; 89(6):101328. PubMed ID: 37734174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Percentage of PNAd-Expressing Vessels is Correlated with Disease Severity in Eosinophilic Chronic Rhinosinusitis.
    Kato E; Tsutsumiuchi T; Muramoto A; Tokunaga T; Fujieda S; Kobayashi M
    Am J Rhinol Allergy; 2023 Jan; 37(1):43-50. PubMed ID: 36172642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of peripheral lymph node addressin in human nasal mucosa with eosinophilic chronic rhinosinusitis.
    Tsutsumiuchi T; Hoshino H; Fujieda S; Kobayashi M
    Pathology; 2019 Apr; 51(3):268-273. PubMed ID: 30837082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic Predictors of Eosinophilic Chronic Rhinosinusitis.
    Ho J; Hamizan AW; Alvarado R; Rimmer J; Sewell WA; Harvey RJ
    Am J Rhinol Allergy; 2018 Jul; 32(4):252-257. PubMed ID: 29862828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-17A facilitates type 2 inflammation in a modified eosinophilic chronic rhinosinusitis mouse model.
    Wu H; Wang Z; Li X; Chen X; Li Y; Huang W; Chang L; Zhang G
    Int Forum Allergy Rhinol; 2023 Sep; 13(9):1726-1737. PubMed ID: 36716409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Formation of nasal polyps: The roles of innate type 2 inflammation and deposition of fibrin.
    Takabayashi T; Schleimer RP
    J Allergy Clin Immunol; 2020 Mar; 145(3):740-750. PubMed ID: 32145873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High chemokine ligand 11 levels in nasal lavage fluid: A potential predictor of and therapeutic target for murine eosinophilic chronic rhinosinusitis.
    Ren X; Wang Z
    Life Sci; 2021 Apr; 271():119218. PubMed ID: 33592198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Group 2 innate lymphoid cells (ILC2s) are increased in chronic rhinosinusitis with nasal polyps or eosinophilia.
    Ho J; Bailey M; Zaunders J; Mrad N; Sacks R; Sewell W; Harvey RJ
    Clin Exp Allergy; 2015 Feb; 45(2):394-403. PubMed ID: 25429730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of interleukin-16 in eosinophilic chronic rhinosinusitis.
    Lackner A; Raggam RB; Stammberger H; Beham A; Braun H; Kleinhappl B; Buzina W; Kittinger C; Reinisch S; Berghold A; Freudenschuss K; Barth S; Marth E
    Eur Arch Otorhinolaryngol; 2007 Aug; 264(8):887-93. PubMed ID: 17431659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HFA-BDP Metered-Dose Inhaler Exhaled Through the Nose Improves Eosinophilic Chronic Rhinosinusitis With Bronchial Asthma: A Blinded, Placebo-Controlled Study.
    Kobayashi Y; Yasuba H; Asako M; Yamamoto T; Takano H; Tomoda K; Kanda A; Iwai H
    Front Immunol; 2018; 9():2192. PubMed ID: 30337921
    [No Abstract]   [Full Text] [Related]  

  • 20. Eosinophil-Derived Osteopontin Induces the Expression of Pro-Inflammatory Mediators and Stimulates Extracellular Matrix Production in Nasal Fibroblasts: The Role of Osteopontin in Eosinophilic Chronic Rhinosinusitis.
    Yang HW; Park JH; Jo MS; Shin JM; Kim DW; Park IH
    Front Immunol; 2022; 13():777928. PubMed ID: 35309360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.